Biotech, cancer, Inflammation Luke Timmerman wrote: Some members of the band that pumped out a one-hit wonder at Icos are getting back together to see if they can produce at least one more hit at Seattle-based Calistoga Pharmaceuticals. Calistoga has been building up its management team over the pas...

BOSTON, MA (MARKET WIRE) In a world in which traditional sources of business advantages like scale and customer knowledge can be easily replicated, Intellectual Property (IP) stands as the main source of sustainable competitive advantage. But because IP is hard to see and generally ignored by establ...

Roundup, deals, Life Sciences Bruce V. Bigelow wrote: It’s hard for any company to raise capital in this recession, but several San Diego life sciences startups disclosed last week they had done just that. A few bright spots also appeared during a local seminar on mergers and acquisitionsR...

Portland, Oregon has been recently declared the most depressed city in the country. BusinessWeek determined this based on "antidepressant sales, suicide rates, unemployment, divorce, and crappy weather." Philly didn't make the top 20 list. That's because we're too busy enjoying......

BIRMINGHAM, ALABAMA (MARKET WIRE) Axcan Pharma is pleased to be part of dreams and magic through its support of the Georgia and Alabama Chapter of the Make-A-Wish Foundation(R). Axcan's recent donation made it possible to fulfill the dream of Gerald, a 12-year-old boy from Alabama suffering from cys...

IRVINE, CA (MARKET WIRE) BIOLASE Technology, Inc. (NASDAQ: BLTI), the world's leading dental laser company, today announced the global launch of its new Waterlase® MD Turbo(TM) hard and soft tissue dental laser system. The most important benefit of the Waterlase MD Turbo is the speed of cutting...

S. 422, a bill introduced by Senator Debbie Stabenow of Michigan earlier this month, has a companion in the House, Lois Capps‘ H.R. 1032. It takes the short title of the “HEART for Women Act of 2009,” with HEART being an acronym for “Heart Disease Education, Analysis Research...

Biotech, cancer, Melanoma Luke Timmerman wrote: Synta Pharmaceuticals reported some disastrous news this afternoon. The Lexington, MA-based biotech company (NASDAQ: SNTA) said it has halted a clinical trial involving more than 630 cancer patients because a greater number of people died after taking ...

Biotech, cancer, Drugs Luke Timmerman wrote: Off the coast of the Bahamas, in sea grass more than a half-mile deep, San Diego-based Nereus Pharmaceuticals found a fungus that may be the key ingredient for an innovative new cancer drug. This will be a key year for gathering evidence that will either ...

When President Obama addresses the nation tonight in a State of the Union fashion, it won't just be Congress and members of the public tuning in. Special interests, too, will be paying close attention to what the president has to say about upcoming plans that could affect them. While the president w...